ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2015 American Transplant Congress

    Adoptive Immunotherapy With Liver Allograft-Derived NK Cells Improves Recurrence-Free Survival After Living-Donor Liver Transplantation in Patients With Hepatocellular Carcinoma

    N. Tanimine, Y. Tanaka, K. Ishiyama, M. Ohira, S. Shimizu, T. Yano, H. Ohdan.

    Department of Gastroenterological and Transplant Surgery, Hiroshima University, Hiroshima, Japan.

    Introduction: Previous studies revealed that the recurrence rate of hepatocellular carcinoma (HCC) was still 10–20%, even among liver transplantation (LT) recipients meeting the Milan criteria…
  • 2015 American Transplant Congress

    Myeloid Cells as a Key Mediator for Impairment of Transplant Tolerance by CMV Infection

    L. Zhang,1 X. Zhang,2 H. Kang,1 X.-F. Liu,2 S. Yan,2 J.-J. Wang,2 M. Abecassis,2 Z. Zhang,2 M. Hummel,2 X. Luo.1,2

    1Medicine, Northwestern University Feinberg school of Medicine, Chicago, IL; 2Comprehensive Transplant Center, Northwestern University Feinberg School of Medicine, Chicago, IL.

    Cytomegalovirus (CMV) is a ubiquitous virus that presents a significant risk for reactivation or de novo infection in transplant recipients. Clinical transplant tolerance has recently…
  • 2015 American Transplant Congress

    Vaccine-Induced 'Incognito' CD8+ T Cell Memory Can Disrupt Transplantation Tolerance

    M. Nelsen,1 K. Beard,2 R. Kedl,1 R. Gill.2

    1Dept of Immunology & Microbiology, Univ of Colorado, Aurora, CO; 2Dept of Surgery, Univ of Colorado, Aurora, CO.

    Transplant recipients harbor immunity to vaccines and pathogens (e.g. CMV, EBV). Pre-existing immunity can have significant antigen-specific ramifications, usually attributed to heterologous immunity, as pathogen-reactive…
  • 2015 American Transplant Congress

    Virus Induced CD28 Down-Regulation as a Potential Driver of Costimulation Blockade Resistant Rejection

    D. Mou,1 J. Espinosa,1 L. Stempora,2 J. Kwun,2 N. Iwakoshi,1 A. Kirk.2

    1Surgery, Emory University, Atlanta, GA; 2Surgery, Duke University, Durham, NC.

    Belatacept, a B7-specific fusion protein, blocks CD28-B7 costimulation and prevents kidney allograft rejection. However, it is ineffective in a sizable minority of patients. Although T…
  • 2015 American Transplant Congress

    Enhanced Requirement for TNF Signaling on Low Affinity Memory CD8+ T Cells During Heterologous Immunity

    S. Krummey,1 C.-W. Chen,1 D. Liu,1 M. Wagener,1 B. Evavold,2 C. Larsen,1 M. Ford.1

    1Emory Transplant Center, Emory University, Atlanta, GA; 2Microbiology and Immunology, Emory University, Atlanta, GA.

    Heterologous immunity, defined as a process during which microbe-specific T cells cross-react with allogeneic antigen and mediate graft rejection, is recognized as a significant barrier…
  • 2015 American Transplant Congress

    Eomes-Expressing CD8+ T Cells and Th17 Cells Mediate Costimulatory Blockade-Resistant Allograft Rejection in Mice

    M. Sabet-Baktach,1 E. Eggenhofer,1 P. Renner,1 M. Lantow,1 H. Schlitt,1 E. Geissler,1 A. Kroemer.1,2

    1Department of Surgery, University Hospital Regensburg, Regensburg, Germany; 2Georgetown Transplant Institute, Georgetown Transplant Institute, Washington, DC.

    The etiology of costimulatory blockade-resistant allograft rejection remains unclear. Therefore, the purpose of this study was to evaluate the responsiveness of distinct CD4+ and CD8+…
  • 2015 American Transplant Congress

    Absence of Allograft TLR4 Receptor Signaling Attenuates Early Inflammation and Promotes Survival of Allografts Subjected to Prolonged Cold Ischemic Storage

    N. Kohei,1 T. Tanaka,1 H. Tsuda,1 D. Kish,1 K. Tanabe,2 R. Fairchild.1

    1Immunology, Cleveland Clinic, Cleveland, OH; 2Urology, Kidney Center, Tokyo Women's Medical University, Tokyo, Japan.

    Endogenous memory CD8 T cells infiltrate MHC-mismatched cardiac allografts and produce IFN-γ in response to donor class І MHC within 24 hrs after graft reperfusion…
  • 2015 American Transplant Congress

    Defining the Role of CD57+CD4 T Cells in Belatacept-Resistant Rejection

    J. Espinosa,1,2 L. Stempora,1,2 R. Townsend,3 A. Kirk.1,2

    1Duke University, Durham, NC; 2Emory University, Atlanta, GA; 3Bristol-Myers Squibb, Princeton, NJ.

    Purpose: We have shown that CD57+PD1- CD4 T cells are present in higher numbers in the peripheral blood and allograft biopsies of patients who experienced…
  • 2015 American Transplant Congress

    T Cell C5a Receptor (C5aR) Signaling Regulates T Follicular Helper Cell (Tfh) Induction

    D. Verghese, P. Heeger.

    Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York, NY.

    Tfh cells, in part via IL-6 dependent production of IL-21, are specialized providers of B cell help. Extending previous work in which we showed that…
  • 2015 American Transplant Congress

    IL-21 Regulates Creation of Tertiary Lymphoid Organs in Chronic Allograft Rejection

    C. Baum,1 M. Khattar,2 P. Schroder,1 W. Chen,3 S. Stepkowski.1

    1Medical Microbiology and Immunology, University of Toledo College of Medicine, Toledo, OH; 2Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA; 3Transplant Immunology Research Program, Houston Methodist Research Institute, Houston, TX.

    BACKGROUND: IL-21 is a cytokine expressed almost exclusively by cells of the adaptive immune system. This makes it an attractive target for reducing chronic allograft…
  • « Previous Page
  • 1
  • …
  • 1365
  • 1366
  • 1367
  • 1368
  • 1369
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences